New innovations are redefining how high-quality DNA is manufactured — delivering complex, high-accuracy genes in less than 48 hours through a fully enzymatic, end-to-end workflow. Meet the new platform combining pristine single-stranded DNA synthesis, ultra-long high-fidelity oligos, automated gene assembly, and bacteria-free processes. This technology enables access to sequences traditionally considered too complex or too slow to produce. Join this talk to gain insights into key performance benchmarks, including high-fidelity synthesis of multi-kilobase genes. Designed to scale from discovery to future GMP-grade output, this platform sets a new standard for precision therapeutics, mRNA vaccines, cell and gene therapies, and advanced research programs.